Abstract:Many human tumors are thought to develop along a multistep pathway in tissues that have encountered long periods of carcinogen exposure and thus have accumulated genetic hits in functional targets relevant to tumor evolution. The cumulative degree of genetic change is dependent on both exogenous (e.g., degree of carcinogen exposure) and endogenous factors (e.g., metabolism of procarcinogens, repair or misrepair capacity, proliferation properties of the tissue, capability of damaged cells to survive). Thus one approach to risk estimation is to measure the accumulated amount of genetic damage in a target tissue at risk for tumor development. Since one cannot predict the exact site of the future tumor, the risk assay must detect a generalized ongoing process of genetic instability from small, random biopsies. The technique of chromosome in situ hybridization involves the use of chromosome- or region-specific probes and provides an ability to directly visualize genetic change (e.g., random or clonal chromosome polysomy and monosomy) on thin tissue sections (where tissue architecture is maintained) or exfoliated cells. Analyses of normal and premalignant lesions adjacent to tumors (e.g., head and neck, lung, bladder, cervix, breast) have demonstrated that chromosome instability can be detected in the field of the tumor (i.e., in normal and premalignant cells in a tissue at 100% risk of tumor development) and the degree of chromosome instability increases with the degree of histologic progression toward cancer. Analyses of premalignant lesions (e.g., oral leukoplakia and erythroplakia from individuals at risk for aerodigestive tract cancer) by chromosome in situ hybridization have uncovered varying degrees of chromosome instability. However, approximately half of those individuals who showed a high degree of chromosome instability in biopsies subsequently developed aerodigestive tract cancer. Of interest, half of these tumors have developed away from the biopsied site, suggesting that the detection of a chromosome instability process in one aspect of the tissue might yield risk information for the total tissue field. These studies also suggest that chromosome in situ hybridization might be useful for identifying individuals with high tumor risk who might benefit from chemopreventive intervention.

Tools used to assay genomic instability in cancers and cancer meiomitosis

Evaluating Chromosome Instability and Genotoxicity Through Single Cell Quantitative Imaging Microscopy

A survey of chromosomal instability measures across mechanistic models

Quantification of Chromosomal Aberrations in Mammalian Cells

An Automated, Single Cell Quantitative Imaging Microscopy Approach to Assess Micronucleus Formation, Genotoxicity and Chromosome Instability

Epigenetic dysregulation from chromosomal transit in micronuclei

Genomic instability: Crossing pathways at the origin of structural and numerical chromosome changes

Detection of chromosome instability of tissue fields at risk: in situ hybridization

Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay.

A pan-cancer compendium of chromosomal instability

The Role of Non-Coding RNAs in Chromosomal Instability in Cancer

Characterizing chromosomal instability-driven cancer evolution and cell fitness at a glance

Endogenous DNA Damage as a Source of Genomic Instability in Cancer

Chromosomal instability as a driver of cancer progression

Specific Mechanisms of Chromosomal Instability Indicate Therapeutic Sensitivities in High-Grade Serous Ovarian Carcinoma

Abstract 4293: Chromosomal instability causes epigenetic aberrations in cancer

A multi-biomarker micronucleus assay using imaging flow cytometry

A survey of CIN measures across mechanistic models

[Recent Progress in Molecular Mechanisms of Chromosome Instability and Their Association with Carcinogenesis].

Genetic Disorders Associated with Cancer Predisposition and Genomic Instability

CINner: modeling and simulation of chromosomal instability in cancer at single-cell resolution